Overall survival from the date of progression.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
A Cumulative of overall survival over 28 days between severe patients... | Download Scientific Diagram
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma | Haematologica
Survival Analysis in R
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
27 Survival analysis | The Epidemiologist R Handbook
Survival Analysis in R
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Survival (time to event) data: median survival times | The BMJ
The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma | Radiation Oncology | Full Text
Entropy | Free Full-Text | Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric Estimators
Understanding Survival Analyses | SpringerLink
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study - The Lancet Public Health
Full article: Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma
27 Survival analysis | The Epidemiologist R Handbook
Kaplan-Meier estimates of cumulative overall survival a | Open-i
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma | Journal of Neuro-Oncology
